Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: Case report and review of the literature

被引:27
作者
Cao, YM
Abbas, J
Wu, XL
Dooley, J
van Amburg, AL
机构
[1] St Lukes Hosp, Dept Internal Med, Chesterfield, MO 63017 USA
[2] St Lukes Hosp, Serv Neurol, Chesterfield, MO 63017 USA
[3] St Lukes Hosp, Oncol Serv, Chesterfield, MO 63017 USA
关键词
ovarian cancer; paraneoplastic cerebellar degeneration (PCD); anti-Yo; pathogenesis;
D O I
10.1006/gyno.1999.5553
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Paraneoplastic cerebellar degeneration (PCD) is a rare nonmetastatic neurological complication in cancer patients. Anti-Yo is one of the anti-onconeural antibodies found in PCD patients. It is believed that anti-Yo occurs almost always in women and is most likely associated with gynecologic or breast cancers, although exceptions exist. Here we report a PCD patient with ovarian cancer having high-titer anti-Yo, The acute onset of her PCD symptoms mimicked that of a stroke, Her ovarian cancer tissue contained abundant plasma cells and lymphocytes. After a thorough review of the literature, we propose a schematic hypothesis for the autoimmune pathogenesis of PCD, Despite anecdotal case reports of neurological improvement with different combinations of treatment, including IVIg, there is still no definitely effective treatment for PCD. Further research on the pathogenesis of PCD may lead to more effective therapies. (C) 1999 Academic Press.
引用
收藏
页码:178 / 183
页数:6
相关论文
共 46 条
[1]   Tumor-specific killer cells in paraneoplastic cerebellar degeneration [J].
Albert, ML ;
Darnell, JC ;
Bender, A ;
Francisco, LM ;
Bhardwaj, N ;
Darnell, RB .
NATURE MEDICINE, 1998, 4 (11) :1321-1324
[2]   PARA-NEOPLASTIC CEREBELLAR DEGENERATION - CLINICAL-IMMUNOLOGICAL CORRELATIONS [J].
ANDERSON, NE ;
ROSENBLUM, MK ;
POSNER, JB .
ANNALS OF NEUROLOGY, 1988, 24 (04) :559-567
[3]  
BenDavid Y, 1996, CANCER-AM CANCER SOC, V78, P2153
[4]   THE INCIDENCE AND COURSE OF PARANEOPLASTIC NEUROPATHY IN WOMEN WITH EPITHELIAL OVARIAN-CANCER [J].
CAVALETTI, G ;
BOGLIUN, G ;
MARZORATI, L ;
MARZOLA, M ;
PITTELLI, MR ;
TREDICI, G .
JOURNAL OF NEUROLOGY, 1991, 238 (07) :371-374
[5]  
COCCONI G, 1985, CANCER, V56, P2318, DOI 10.1002/1097-0142(19851101)56:9<2318::AID-CNCR2820560930>3.0.CO
[6]  
2-9
[7]  
Corradi JP, 1997, J NEUROSCI, V17, P1406
[8]   Regulation of class I MHC gene expression in the developing and mature CNS by neural activity [J].
Corriveau, RA ;
Huh, GS ;
Shatz, CJ .
NEURON, 1998, 21 (03) :505-520
[9]   Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: A long-term survey of ovarian cancer patients [J].
Drlicek, M ;
Bianchi, G ;
Bogliun, G ;
Casati, B ;
Grisold, W ;
Kolig, C ;
LiszkaSetinek, U ;
Marzorati, L ;
Wondrusch, E ;
Cavaletti, G .
JOURNAL OF NEUROLOGY, 1997, 244 (02) :85-89
[10]  
Dropcho Edward J., 1995, Annals of Neurology, V37, pS102